Aurobindo Pharma USA, Inc. · 16 hours ago
QA Product Complaint Coordinator
Aurobindo Pharma USA, Inc. is a generic pharmaceutical manufacturer and distributor committed to delivering quality, affordable generic pharmaceuticals. The QA Product Complaint Coordinator is responsible for handling product complaints, ensuring accurate investigations, and assisting with medical inquiries and adverse drug events.
BiotechnologyPharmaceutical
Responsibilities
Handling product complaints: initiating/receiving, processing and closing as per applicable standard operating procedures (SOP)
Prepare complaint samples for shipment to manufacturing unit for investigation
Interacting/doing follow-up with the customer/reporter on a daily basis to acquire information that may be required to effectively investigate a product complaint
Reviewing the final investigations received from the manufacturing units to ensure accuracy
To assist in appropriately handling initial receipt of ADE and processing it as per applicable SOPs
As deemed necessary, to assist in the handling and processing of field alert reports to FDA
Qualification
Required
Must be able to work in the US without requiring sponsorship
Must be cordial and responsible while talking to customers, complainants or other associates
Must be very organized and possess high standard work ethics
Effective communication, attentive listening is a must. Skill to record the information received promptly and correctly on the appropriate documentation form is a must
Must be cooperative when assigned other responsibilities
Must be proficient in using Excel and Word
Minimum of Bachelor of Science. or equivalent professional experience
Minimum one year experience working in Pharmacovigilance, Customer Service, or related role in Healthcare industry
Preferred
Bilingual in Spanish preferred, not required
Company
Aurobindo Pharma USA, Inc.
Aurobindo Pharma is a pharmaceuticals company offering generic pharmaceuticals.
Funding
Current Stage
Late StageRecent News
2025-06-28
Business Standard India
2024-11-25
2024-11-24
Company data provided by crunchbase